Gabriela A Fiorentino1,2, Elizabeth Miliwebsky3, María Victoria Ramos2, Gisela Zolezzi3, Isabel Chinen3, Glenda Guzmán1, Rubén Nocera1, Romina Fernández-Brando2, Adriana Santiago4, Ramón Exeni4, Marina S Palermo5. 1. Laboratorio del Hospital de Niños "Prof Dr Ramón Exeni", Provincia de Buenos Aires, San Justo, Argentina. 2. Instituto de Medicina Experimental (IMEX)-CONICET- Academia Nacional de Medicina, Buenos Aires, Argentina. 3. Servicio Fisiopatogenia, Instituto Nacional de Enfermedades Infecciosas-ANLIS Dr. Carlos G. Malbrán, Buenos Aires, Argentina. 4. Departamento de Nefrología, Hospital Municipal de Niños "Prof Dr Ramón Exeni", Provincia de Buenos Aires, San Justo, Argentina. 5. Instituto de Medicina Experimental (IMEX)-CONICET- Academia Nacional de Medicina, Buenos Aires, Argentina. marinasandrapalermo@gmail.com.
Abstract
BACKGROUND: Hemolytic uremic syndrome (HUS) is characterized by microangiopathic hemolysis, thrombocytopenia, and thrombus formation leading to tissue injury. HUS is classified according to its etiology as post-diarrheal or atypical HUS. Differential diagnosis of both entities continues to be a challenge for pediatric physicians. METHODS: The aim was to improve the rapid etiological diagnosis of post-diarrheal HUS cases based on the detection of Shiga toxin (Stx)-producing Escherichia coli (STEC) infection by screening of stx1/stx2 and rfbO157 in cultured stools by multiplex PCR, and the additional detection of anti-lipopolysaccharide (anti-LPS) O157, O145, and O121 antibodies by Glyco-iELISA test. In addition, we studied patients' relatives to detect circulating pathogenic strains that could contribute to HUS diagnosis and/or lead to the implementation of measures to prevent dissemination of familial outbreaks. This study describes the diagnosis of 31 HUS patients admitted to Hospital Municipal de Niños Prof Dr Ramón Exeni during the 2017-2020 period. RESULTS: Stool PCR confirmed the diagnosis of STEC associated with HUS in 38.7% of patients (12/31), while anti-LPS serology did in 88.9% (24/27). In those patients in which both methods were carried out (n = 27), a strong association between the results obtained was found. We found that 30.4% of HUS patients had at least one relative positive for STEC. CONCLUSIONS: We could identify 96.3% (26/27) of HUS cases as secondary to STEC infections when both methods (genotyping and serology) were used. The results demonstrated a high circulation of STEC in HUS families and the prevalence of the STEC O157 serotype (83%) in our pediatric cohort. A higher-resolution version of the Graphical abstract is available as Supplementary information.
BACKGROUND: Hemolytic uremic syndrome (HUS) is characterized by microangiopathic hemolysis, thrombocytopenia, and thrombus formation leading to tissue injury. HUS is classified according to its etiology as post-diarrheal or atypical HUS. Differential diagnosis of both entities continues to be a challenge for pediatric physicians. METHODS: The aim was to improve the rapid etiological diagnosis of post-diarrheal HUS cases based on the detection of Shiga toxin (Stx)-producing Escherichia coli (STEC) infection by screening of stx1/stx2 and rfbO157 in cultured stools by multiplex PCR, and the additional detection of anti-lipopolysaccharide (anti-LPS) O157, O145, and O121 antibodies by Glyco-iELISA test. In addition, we studied patients' relatives to detect circulating pathogenic strains that could contribute to HUS diagnosis and/or lead to the implementation of measures to prevent dissemination of familial outbreaks. This study describes the diagnosis of 31 HUS patients admitted to Hospital Municipal de Niños Prof Dr Ramón Exeni during the 2017-2020 period. RESULTS: Stool PCR confirmed the diagnosis of STEC associated with HUS in 38.7% of patients (12/31), while anti-LPS serology did in 88.9% (24/27). In those patients in which both methods were carried out (n = 27), a strong association between the results obtained was found. We found that 30.4% of HUS patients had at least one relative positive for STEC. CONCLUSIONS: We could identify 96.3% (26/27) of HUS cases as secondary to STEC infections when both methods (genotyping and serology) were used. The results demonstrated a high circulation of STEC in HUS families and the prevalence of the STEC O157 serotype (83%) in our pediatric cohort. A higher-resolution version of the Graphical abstract is available as Supplementary information.
Authors: G A Leotta; I Chinen; S Epszteyn; E Miliwebsky; I C Melamed; M Motter; M Ferrer; E Marey; M Rivas Journal: Rev Argent Microbiol Date: 2005 Jan-Mar Impact factor: 1.852
Authors: M Rivas; E Miliwebsky; I Chinen; C D Roldán; L Balbi; B García; G Fiorilli; S Sosa-Estani; J Kincaid; J Rangel; P M Griffin Journal: Foodborne Pathog Dis Date: 2006 Impact factor: 3.171
Authors: Laura F Alconcher; Paula A Coccia; Angela Del C Suarez; Marta L Monteverde; María Graciela Perez Y Gutiérrez; Paula M Carlopio; Mabel L Missoni; Alejandro Balestracci; Illiana Principi; Flavia B Ramírez; Patricia Estrella; Susana Micelli; Daniela C Leroy; Nahir E Quijada; Claudia Seminara; Marta I Giordano; Susana B Hidalgo Solís; Mariana Saurit; Alejandra Caminitti; Andrea Arias; Marta Rivas; Paula Risso; Miguel Liern Journal: Pediatr Nephrol Date: 2018-06-30 Impact factor: 3.714
Authors: Laura F Alconcher; Alejandro Balestracci; Paula A Coccia; Angela Del C Suarez; Flavia B Ramírez; Marta L Monteverde; María Graciela Perez Y Gutiérrez; Paula M Carlopio; Illiana Principi; Patricia Estrella; Susana Micelli; Daniela C Leroy; Nahir E Quijada; Claudia Seminara; Marta I Giordano; Susana B Hidalgo Solís; Mariana Saurit; Alejandra Caminitti; Andrea Arias; Miguel Liern; Marta Rivas Journal: Pediatr Nephrol Date: 2021-02-18 Impact factor: 3.714
Authors: Justin B Ludwig; Xiaorong Shi; Pragathi B Shridhar; Elisabeth L Roberts; Chitrita DebRoy; Randy K Phebus; Jianfa Bai; T G Nagaraja Journal: Front Cell Infect Microbiol Date: 2020-07-29 Impact factor: 5.293